Risplom 1 Tablet contains Risperidone 1mg, an atypical antipsychotic widely used for managing schizophrenia, bipolar disorder, and irritability associated with autism. It helps in controlling psychotic symptoms, mood swings, and aggression.
Risperidone works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, stabilizing neurotransmission in the brain for effective symptom control with minimal side effects.
Tablet formulation ensures accurate dosing, patient-friendly administration, and improved adherence. Its strong clinical acceptance makes it a high-demand product in mental health clinics, hospitals, and pharmacies.
Adding Risplom 1 Tablet to your neuropsychiatric and antipsychotic portfolio enhances your offerings with a trusted, fast-moving therapy. Its prescriber confidence, patient use, and export suitability make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.
Common side effects may include drowsiness, dizziness, weight gain, increased appetite, nausea, or dry mouth. Rare but serious side effects include extrapyramidal symptoms (movement disorders), tardive dyskinesia, neuroleptic malignant syndrome, or severe allergic reactions. Medical attention should be sought if severe symptoms occur.
Risplom 1 Tablet is indicated for the treatment of schizophrenia, bipolar disorder (mania or mixed episodes), and irritability associated with autism spectrum disorders, as prescribed by a healthcare professional.
Risplom 1 Tablet should be taken exactly as prescribed. Avoid sudden discontinuation, as it may worsen symptoms. Caution is advised in patients with heart disease, seizure disorders, or liver/kidney impairments. Inform the doctor about any other medications being taken.
Store Risplom 1 Tablet in a cool, dry place away from direct sunlight. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.